On Mar 15, 2022 PrognomiQ closed a Venture – Series Unknown round and raised $46,000,000 from aMoon Fund, Bruker, Catalio Capital Management, Emerson Collective, Fidelity […]
Venture Round – PrognomiQ
On Mar 15, 2022 PrognomiQ closed a Venture – Series Unknown round and raised $46,000,000 from aMoon Fund, Bruker, Catalio Capital Management, Emerson Collective, Fidelity […]
Grant – Cache DNA
On Mar 14, 2022 Cache DNA closed a Grant round and raised $256,000 from NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR), […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Series B – Epsilogen
On Mar 2, 2022 Epsilogen closed a Series B round and raised £30,750,000 from 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, […]
Series A – Rondo Therapeutics
On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, […]
Post-IPO Equity – BioVaxys
On Feb 28, 2022 BioVaxys closed a Post-IPO Equity round and raised $798,500 from investors, featuring lead investors . About the company: BioVaxys is located […]
